Literature DB >> 32420936

Treatments for COVID-19: emerging drugs against the coronavirus.

Francesco Potì1, Cristina Pozzoli2, Maristella Adami3, Enzo Poli4, Lucio G Costa5.   

Abstract

The Coronavirus disease 19 (COVID-19) outbreak has been recognized as a global threat to public health. It is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and no effective therapies currently exist against this novel viral agent. Along with extensive public health measures, an unprecedented global effort in identifying effective drugs for the treatment is being implemented. Potential drug targets are emerging as the result of a fast-evolving understanding of SARS-CoV-2 virology, host response to the infection, and clinical course of the disease. This brief review focuses on the latest and most promising pharmacological treatments against COVID-19 currently under investigation and discuss their potential use based on either documented efficacy in similar viral infections, or their activity against inflammatory syndromes. Ongoing clinical trials are also emphasized.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32420936     DOI: 10.23750/abm.v91i2.9639

Source DB:  PubMed          Journal:  Acta Biomed        ISSN: 0392-4203


  8 in total

1.  COVID-19 … What are drugs and strategies now?

Authors:  Valentina Bellini; Andrea Cortegiani; Luigi Vetrugno; Francesco Potì; Francesco Saturno; Michelangelo Craca; Elena Bignami
Journal:  Acta Biomed       Date:  2021-05-12

Review 2.  A review on the interaction of nucleoside analogues with SARS-CoV-2 RNA dependent RNA polymerase.

Authors:  Suliman Khan; Farnoosh Attar; Samir Haj Bloukh; Majid Sharifi; Faisal Nabi; Qian Bai; Rizwan Hasan Khan; Mojtaba Falahati
Journal:  Int J Biol Macromol       Date:  2021-03-22       Impact factor: 8.025

3.  Untargeted plasma metabolomic fingerprinting highlights several biomarkers for the diagnosis and prognosis of coronavirus disease 19.

Authors:  Céline Occelli; Jean-Marie Guigonis; Sabine Lindenthal; Alexandre Cagnard; Fanny Graslin; Vesna Brglez; Barbara Seitz-Polski; Jean Dellamonica; Jacques Levraut; Thierry Pourcher
Journal:  Front Med (Lausanne)       Date:  2022-09-29

Review 4.  Review of adverse cutaneous reactions of pharmacologic interventions for COVID-19: A guide for the dermatologist.

Authors:  Antonio Martinez-Lopez; Carlos Cuenca-Barrales; Trinidad Montero-Vilchez; Alejandro Molina-Leyva; Salvador Arias-Santiago
Journal:  J Am Acad Dermatol       Date:  2020-08-07       Impact factor: 11.527

Review 5.  Race to arsenal COVID-19 therapeutics: Current alarming status and future directions.

Authors:  Ankit Kumar Dubey; Aakansha Singh; Shardendu Prakash; Manoj Kumar; Ashok K Singh
Journal:  Chem Biol Interact       Date:  2020-10-27       Impact factor: 5.192

6.  Treatments for COVID-19: emerging drugs against the coronavirus.

Authors:  Sara Khademolhosseini; Hadiseh Kavandi; Samad Ghaffari
Journal:  Acta Biomed       Date:  2020-06-30

7.  Treatments for COVID-19: emerging drugs against the coronavirus - reply.

Authors:  Francesco Potì
Journal:  Acta Biomed       Date:  2020-06-30

Review 8.  How to overcome cardiovascular challenges in COVID-19 patients: a guide for common practice.

Authors:  Pegah Eslami; Mohammadreza Tabary; Arash Dooghaie-Moghadam; Isa Khaheshi
Journal:  Acta Biomed       Date:  2020-09-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.